Femasys Inc. (NASDAQ:FEMY) Short Interest Up 72.5% in April

Femasys Inc. (NASDAQ:FEMYGet Rating) saw a large increase in short interest in the month of April. As of April 30th, there was short interest totalling 227,200 shares, an increase of 72.5% from the April 15th total of 131,700 shares. Approximately 2.6% of the company’s shares are sold short. Based on an average trading volume of 210,300 shares, the days-to-cover ratio is presently 1.1 days.

FEMY has been the subject of a number of recent analyst reports. HC Wainwright initiated coverage on Femasys in a report on Thursday, March 24th. They set a “buy” rating and a $8.00 price objective for the company. Chardan Capital dropped their price objective on Femasys from $25.00 to $18.00 and set a “buy” rating for the company in a report on Friday, March 25th.

FEMY opened at $1.49 on Friday. The firm has a market cap of $17.59 million and a price-to-earnings ratio of -1.45. The company has a current ratio of 15.15, a quick ratio of 15.03 and a debt-to-equity ratio of 0.01. Femasys has a 12 month low of $1.40 and a 12 month high of $13.75. The stock has a fifty day moving average price of $1.85 and a 200-day moving average price of $3.33.

Femasys (NASDAQ:FEMYGet Rating) last released its quarterly earnings results on Thursday, March 24th. The company reported ($0.08) EPS for the quarter. The firm had revenue of $0.25 million during the quarter. On average, equities research analysts forecast that Femasys will post -0.93 EPS for the current year.

A number of hedge funds have recently made changes to their positions in FEMY. Oppenheimer & Co. Inc. purchased a new position in Femasys during the 4th quarter worth $514,000. CM Management LLC grew its stake in Femasys by 125.0% during the 1st quarter. CM Management LLC now owns 225,000 shares of the company’s stock worth $509,000 after buying an additional 125,000 shares during the last quarter. Vanguard Group Inc. purchased a new position in Femasys during the 1st quarter worth $269,000. First National Corp MA ADV purchased a new position in Femasys during the 1st quarter worth $168,000. Finally, Clear Creek Financial Management LLC grew its stake in Femasys by 190.2% during the 4th quarter. Clear Creek Financial Management LLC now owns 68,276 shares of the company’s stock worth $266,000 after buying an additional 44,752 shares during the last quarter. Hedge funds and other institutional investors own 4.54% of the company’s stock.

About Femasys (Get Rating)

Femasys Inc, a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing.

Featured Stories

Receive News & Ratings for Femasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Femasys and related companies with MarketBeat.com's FREE daily email newsletter.